XNCR Q4 2025 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$890M

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$28M-59.7% YoY

Gross Profit

$26M90.9% margin

Operating Income

-$54M-189.9% margin

Net Income

-$7M-23.6% margin

EPS (Diluted)

$-0.09

QoQ Revenue Growth

+34.5%

Cash Flow

Operating Cash Flow

-$52M

Free Cash Flow

-$53M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$875M

Total Liabilities

$240M

Stockholders' Equity

$636M

Cash & Equivalents

$54M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$28M	$70M	-59.7%
Gross Profit	$26M	$70M	-63.4%
Operating Income	-$54M	$4M	-1425.1%
Net Income	-$7M	-$53M	+87.6%

Revenue Segments

Royalty

$22M79%

Milestone

$6M21%